Thasler Wolfgang E., Weiss Thomas S., Schillhorn Kerrin, Stoll Peter-Tobias, Irrgang Bernhard, Jauch Karl-Walter
Center for Livercell Research, University of Regensburg Hospital, D-93042 Regensburg, Germany; Department of Surgery, Klinikum Grosshadern LM University of Munich, D-81377 Munich, Germany; Author for correspondence (Tel.: +49-941 944 6837; Fax: +49-941 944 6838; E-mail:
Cell Tissue Bank. 2003;4(1):49-56. doi: 10.1023/A:1026392429112.
Tissue engineering using human cells and tissue has one of the greatest scientific and economical potential in the coming years. There are public concerns during the ongoing discussion about future trends in life sciences and if ethic boundaries might be respected sufficiently in the course of striving for industrial profit and scientific knowledge. Until now, the legal situation of using human tissue material for research is not clear. Accordingly, transparency of action and patients' information are a central component when handling patient material inside and outside of the patient-specific treatment. Whereas in the field of therapeutic use of tissue (e.g. transplantation) there is an emergency situation by the shortage of organs with the risk of the premature death of the potential recipient, this cannot be claimed for tissue donation for research. The basis of every surgical operation is the treatment contract, which places the doctor under obligation to the careful exercise of medical treatment containing the patient's informed consent. This contract only covers the treatment that is intended to cure the patient and the medical measures that are necessary therefor. The further scientific use of body-substances, which are discarded after an operation, are not included. Therefore a personal and independent written enlightenment of the patient and a declaration of informed consent is necessary. Examples of guidelines for tissue supply, Patients information and consent were worked out by theologists, lawyers, scientists and physicians reflecting their practical experience in transplant surgery and liver cell research. As a consequence to cover the ethical and legal aspect of tissue donation in Germany a charitable state-controlled foundation Human Tissue and Cell Research (HTCR) was introduced and established.
利用人类细胞和组织进行的组织工程在未来几年具有巨大的科学和经济潜力。在当前关于生命科学未来趋势的讨论中,公众担心在追求产业利润和科学知识的过程中,伦理界限是否能得到充分尊重。到目前为止,将人体组织材料用于研究的法律状况尚不明朗。因此,在针对特定患者的治疗内外处理患者材料时,行动的透明度和患者信息是核心要素。在组织治疗应用领域(如移植),由于器官短缺,潜在接受者面临过早死亡的风险,存在紧急情况,但对于用于研究的组织捐赠则不能如此声称。每一次外科手术的基础都是治疗合同,该合同使医生有义务谨慎实施包含患者知情同意的医疗治疗。这份合同仅涵盖旨在治愈患者的治疗以及为此所需的医疗措施。手术之后废弃的身体物质的进一步科学利用并不包括在内。因此,需要对患者进行个人独立的书面告知并获得知情同意声明。神学家、律师、科学家和医生根据他们在移植手术和肝细胞研究中的实践经验,制定了组织供应、患者信息和同意方面的指导方针示例。结果,为了涵盖德国组织捐赠的伦理和法律方面,设立并成立了一个由国家控制的慈善基金会——人体组织和细胞研究基金会(HTCR)。